acetazolamide has been researched along with Encephalitis in 3 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Encephalitis: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At 4 weeks and 8 months following initial symptoms, we performed single-photon emission computed tomography (SPECT) with acetazolamide (ACZ) testing in a patient recovering from acute encephalitis, possibly acute disseminated encephalomyelitis (ADEM)." | 7.71 | Hypoperfusion following encephalitis: SPECT with acetazolamide. ( Ashida, KI; Imaizumi, M; Okamoto, M, 2001) |
| "Cerebral vasoreactivity to acetazolamide is preserved in patients with severe sepsis." | 3.80 | Assessment of cerebral tissue oxygen saturation in septic patients during acetazolamide provocation - a near infrared spectroscopy study. ( Fülesdi, B; László, I; Molnár, C; Molnár, L; Siró, P; Szatmári, S; Vaskó, A, 2014) |
| "At 4 weeks and 8 months following initial symptoms, we performed single-photon emission computed tomography (SPECT) with acetazolamide (ACZ) testing in a patient recovering from acute encephalitis, possibly acute disseminated encephalomyelitis (ADEM)." | 3.71 | Hypoperfusion following encephalitis: SPECT with acetazolamide. ( Ashida, KI; Imaizumi, M; Okamoto, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaskó, A | 1 |
| Siró, P | 1 |
| László, I | 1 |
| Szatmári, S | 1 |
| Molnár, L | 1 |
| Fülesdi, B | 1 |
| Molnár, C | 1 |
| Battaglia, F | 1 |
| Franques, J | 1 |
| Somma-Mauvais, H | 1 |
| Roche, PH | 1 |
| Okamoto, M | 1 |
| Ashida, KI | 1 |
| Imaizumi, M | 1 |
3 other studies available for acetazolamide and Encephalitis
| Article | Year |
|---|---|
Assessment of cerebral tissue oxygen saturation in septic patients during acetazolamide provocation - a near infrared spectroscopy study.
Topics: Acetazolamide; Aged; Aged, 80 and over; Brain; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Case-C | 2014 |
[Clinical presentation suggesting Bickerstaff encephalitis and intracranial hypertension].
Topics: Acetazolamide; Diuretics; Electroencephalography; Electromyography; Encephalitis; Gait Disorders, Ne | 2011 |
Hypoperfusion following encephalitis: SPECT with acetazolamide.
Topics: Acetazolamide; Adult; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Encephaliti | 2001 |